France / Français
A biotech that's developing a drug for a rare metabolic disorder is exploring going public in 2019
1 month ago - By Business Insider
New York-based biotech Applied Therapeutics is exploring an initial public offering in the first half of 2019, according to people familiar with the matter.
The company's developing a drug for a rare metabolic disorder, as well as treatments for diabetes complications.
The red hot market for biotech IPOs may have another entrant.
New York-based Applied Therapeutics, which is developing treatments for cardio-metabolic conditions, is exploring an IPO that could land in first half of next year, according to people familiar with the matter.
The people cautioned that timing could change...
Read more ...
Search by Tags
Marketing Fund Investments New York Invest Market Companies Investment Company Land Management
The headlines of Business Mag
HOLD FAMILY A multiplayer network game for families
Spend more time with your family and less with your phone with the Hold Family app made by us! :)
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
The Dow erases more than 300-point gain after Trump threatens government...
Wall Street wiped out earlier gains Tuesday after political headlines overshadowed trade optimism. The S&P 500 shed 4.6% last week, the most since March. Watch the major US...
Dow Jones Industrial Average rallies 100 points on U.S.-China trade hopes
From CHRIS MATTHEWS & Barbara Kollmeyer : U.S. stocks rose modestly higher Tuesday, off early morning highs, on renewed optimism over U.S.-China trade talks, a day after...
Amazon isn't getting enough credit for creating jobs, Morgan Stanley says
Amazon 's impact on the job market has been underappreciated, Morgan Stanley says. The retailer is both directly and indirectly creating a massive number of jobs on the...
A New Target for the Price of Silver
From Peter Krauth : There's no question the price of silver has made some bullish moves this week. The silver price has climbed by 3% over that time, aided by a weak U.S...
Dell votes in favor of going public again
Dell announced Tuesday that it has agreed to buy back the publicly traded "tracking" shares of VMware, a listed company that is about 80% owned by Dell. The company confirmed...
Gold's price remains steady even as British Pound falls and U.S. Dollar...
From Gary Wagner : In light of an extremely strong U.S. dollar, gold is holding up quite well today. We only need to look at the KGX to illustrate that point. As of 5:00 PM...
A New Wrinkle in the U.S.-Canada Trade Dispute
Last week I had the opportunity to attend the Young Presidents Organization parliamentary intelligence forum in Washington, D.C. More than 200 members of parliaments from as...
'No place to hide': The stock market's sell-off has left investors...
US stocks are set to close out 2018 well off their highs, but each trampled sector's sell-off since the beginning of October has been quite different, according to a Wells...
U.S. Hotel Stocks Up 1.6% in November
Year to date through the first 11 months of 2018, the stock index fell 9.0%.
10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA...
Here is what you need to know. The 'Trump Trade' has finally evaporated entirely. The ratio between more growth-sensitive cyclical stocks and their defensive counterparts has...